Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease

NCT01221766 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT01221766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01221766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease
Lead sponsor
Dana-Farber Cancer Institute
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
October 31, 2014
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cgvhd, chronic graft vs host disease, graft vs host disease